1. Li, Jing, Xu, Xiaoqin, Peng, Xiting. 2022. NDC80 Enhances Cisplatin-resistance in Triple-negative Breast Cancer. In Archives of medical research, 53, 378-387. doi:10.1016/j.arcmed.2022.03.003. https://pubmed.ncbi.nlm.nih.gov/35346500/
2. Ju, Lin-Ling, Chen, Lin, Li, Jun-Hong, Bian, Zhao-Lian, Shao, Jian-Guo. . Effect of NDC80 in human hepatocellular carcinoma. In World journal of gastroenterology, 23, 3675-3683. doi:10.3748/wjg.v23.i20.3675. https://pubmed.ncbi.nlm.nih.gov/28611520/
3. Fang, Leiming, Liu, Qi, Cui, Hongtu, Zheng, Yunji, Wu, Chengjun. 2022. Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers. In Genes, 13, . doi:10.3390/genes13040654. https://pubmed.ncbi.nlm.nih.gov/35456460/
4. Ye, Weijie, Liang, Xisong, Chen, Ge, Cheng, Quan, Chen, Xiaoping. . NDC80/HEC1 promotes macrophage polarization and predicts glioma prognosis via single-cell RNA-seq and in vitro experiment. In CNS neuroscience & therapeutics, 30, e14850. doi:10.1111/cns.14850. https://pubmed.ncbi.nlm.nih.gov/39021287/
5. Shan, Jijun, Jiang, Wangjie, Chang, Jiang, Li, Changxian, Li, Xiangcheng. 2023. NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1. In International journal of biological sciences, 19, 1336-1351. doi:10.7150/ijbs.80737. https://pubmed.ncbi.nlm.nih.gov/37056930/
6. Liu, Bo, Yao, Zhicheng, Hu, Kunpeng, Yang, Yang, Ren, Jie. 2015. ShRNA-mediated silencing of the Ndc80 gene suppress cell proliferation and affected hepatitis B virus-related hepatocellular carcinoma. In Clinics and research in hepatology and gastroenterology, 40, 297-303. doi:10.1016/j.clinre.2015.08.002. https://pubmed.ncbi.nlm.nih.gov/26382282/
智鼠故事 
